4//SEC Filing
Duncan Barbara Gayle 4
Accession 0000950170-24-074985
CIK 0001593899other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 5:00 PM ET
Size
6.8 KB
Accession
0000950170-24-074985
Insider Transaction Report
Form 4
Duncan Barbara Gayle
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-16+33,150→ 33,150 total - Exercise/Conversion
Restricted Stock Units
2024-06-16−33,150→ 0 total→ Common Stock (33,150 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The restricted stock units are fully vested.
- [F3]The restricted stock units do not have an expiration date.
Documents
Issuer
Atea Pharmaceuticals, Inc.
CIK 0001593899
Entity typeother
Related Parties
1- filerCIK 0001353128
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 5:00 PM ET
- Size
- 6.8 KB